Every 10-Q that The Sherwin-Williams Company (SHW) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow SHW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SHW filings page.
The Sherwin-Williams Company reported higher results for the quarter and six months ended June 30, 2026. Consolidated net sales rose 7.5% in the quarter to $6,789.3 million and 7.2% year to date to $12,456.2 million, with growth in all three segments and contributions from the 2025 Suvinil acquisition. Management reports diluted EPS increased 14.3% to $3.43, with adjusted diluted EPS up to $3.70; for the first half, diluted EPS was $5.58 and adjusted diluted EPS $6.05. Net income for the quarter was $843.6 million.
Gross margin remained around 49% despite moderately higher raw material costs and the dilutive impact of Suvinil, while SG&A stayed roughly stable as a percentage of sales. Net operating cash flow improved to $1,486.6 million in the first six months versus $1,051.5 million a year earlier. At June 30, 2026, total assets were $26,951.4 million and total debt $12,072.1 million, with cash and equivalents of $293.5 million and $1.969 billion of unused credit capacity. The company repurchased 5.6 million shares for $1,837.0 million year to date and paid dividends of $1.60 per share.
The Sherwin-Williams Company reported higher first-quarter 2026 results. Net sales rose 6.8% to $5.667 billion, driven by growth in all segments and contributions from the Suvinil acquisition plus favorable foreign currency.
Net income increased to $534.7 million, with diluted earnings per share up 7.5% to $2.15. Adjusted diluted EPS reached $2.35. Gross margin improved to 49.1% from 48.2% as moderating raw material costs and mix offset higher selling, general and administrative expenses.
Net operating cash was $139.1 million versus a prior-year use of cash, while EBITDA was $998.2 million. The company ended the quarter with $216.9 million in cash, total debt of $11.7 billion and 246.6 million common shares outstanding. Management highlights disciplined capital deployment, ongoing share repurchases and strong liquidity, including $2.443 billion of unused credit capacity.
The Sherwin-Williams Company reported Q3 results with net sales of $6,358.2 million, up modestly year over year. Net income was $833.1 million and diluted EPS was $3.35. Gross margin was 49.2% and SG&A was 30.7% of sales, both essentially flat versus last year.
Year to date, operating cash flow reached $2,359.1 million, while capital expenditures were $567.2 million. The company repurchased $668.2 million of shares in Q3 (2,000,000 shares at an average price of $334.10) and paid a quarterly dividend of $0.79 per share. Shares outstanding were 247,893,513 as of September 30, 2025.
Balance sheet highlights include total assets of $26,206.4 million and total debt of $11,515.5 million. In July, the company issued $1.5 billion of senior notes and repaid 2025 maturities and commercial paper. As a subsequent event, Sherwin-Williams completed the Suvinil acquisition in Brazil for $1.150 billion, funded through a delayed draw term loan.